side effects of glp-1 drugs Struggling with therapy effects? You're not alone. This Clinician Guide: Managing Common GLP-1 Receptor Agonist Side provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects GI Adverse Effects of Glucagon-Like

Currently, there is limited interest in the non-GLP-1R obesity field, as sales for obesity drugs targeting alternative mechanisms are only forecast to generate a mere $310m in 2026

The potential role of glucagon-like peptide 1 in diabetes

The present state of GLP-1 therapeutics demonstrates considerable progress from first-generation short-acting agents to advanced long-acting analogues and innovative oral formulations

doi: 10.1038/nn1969 172 SalcedoI.TweedieD.LiY.GreigN

As cardiovascular risk climbs after menopause, we know that when we lose our estrogen, our risk for cardiovascular events goes up, up, up

Structural alterations of the ligand peptides as in GIP/GLP-1 dual-receptor agonists may alter these cellular processes strongly and may explain that an antagonist may activate while an agonist may block receptor signaling (4649)